These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19281719)

  • 1. Comparison of podophyllotoxin and imiquimod as anal condyloma acuminata therapy.
    Krishna S
    Dermatol Online J; 2009 Jan; 15(1):14. PubMed ID: 19281719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of anal and perianal condyloma acuminata with imiquimod.
    Tawada C; Oshitani Y; Kimura M; Seishima M
    Acta Derm Venereol; 2014 Jan; 94(1):118-9. PubMed ID: 23824207
    [No Abstract]   [Full Text] [Related]  

  • 3. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
    Lafuma A; Monsonego J; Moyal-Barracco M; Pribil C
    Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of external ano-genital condylomata with 0.5% podophyllotoxin].
    Aynaud O; Tranbaloc P
    Contracept Fertil Sex; 1995 Feb; 23(2):127-30. PubMed ID: 7894544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
    Schöfer H
    Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
    Cox JT
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():51-4. PubMed ID: 14616817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of imiquimod for anogenital warts.
    Birley H; Clark F; Sparks R
    Int J STD AIDS; 2002 Sep; 13(9):647; author reply 647-8. PubMed ID: 12230931
    [No Abstract]   [Full Text] [Related]  

  • 8. Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata.
    Yan J; Chen SL; Wang HN; Wu TX
    Dermatology; 2006; 213(3):218-23. PubMed ID: 17033171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatments for genital warts less than ideal: abstract and commentary.
    Fife KH
    JAMA; 1998 Jun; 279(24):2003-4. PubMed ID: 9643868
    [No Abstract]   [Full Text] [Related]  

  • 10. Anal condyloma treatment and recurrence in HIV-negative men who have sex with men.
    Silvera RJ; Smith CK; Swedish KA; Goldstone SE
    Dis Colon Rectum; 2014 Jun; 57(6):752-61. PubMed ID: 24807601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatments for anal condylomata acuminata.
    Mistrangelo M; Dal Conte I; Volpatto S; DI Benedetto G; Testa V; Currado F; Morino M
    Minerva Chir; 2018 Feb; 73(1):100-106. PubMed ID: 29154519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for the response to treatment in males with genital warts.
    Stefanaki C; Hadjivassiliou M; Katzouranis I; Bethimoutis G; Nicolaidou E; Anyfantakis V; Lagogianni E; Caroni C; Panagiotopoulos A; Antoniou C; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1156-60. PubMed ID: 19453776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
    Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
    Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy.
    Saiag P; Bourgault-Villada I; Pavlovic M; Roudier-Pujol C
    AIDS; 2002 Jul; 16(10):1438-40. PubMed ID: 12131230
    [No Abstract]   [Full Text] [Related]  

  • 15. A short, 8-week course of imiquimod 5% cream versus podophyllotoxin in the treatment of anogenital warts: A retrospective comparative cohort study.
    Nicolaidou E; Kanelleas A; Nikolakopoulos S; Bezrodnii G; Nearchou E; Gerodimou M; Papadopoulou-Skordou E; Paparizos V; Rigopoulos D
    Indian J Dermatol Venereol Leprol; 2021; 87(5):666-670. PubMed ID: 31650979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
    Gayed SL
    Int J STD AIDS; 2002 Jul; 13(7):501-3. PubMed ID: 12171672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
    Gayed SL
    Int J STD AIDS; 2002 May; 13(5):349-51. PubMed ID: 11972940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medico-economic analysis of therapy of external condylomata acuminata].
    Fagnani F
    Ann Dermatol Venereol; 2000; 127(10 Suppl):3S27-3S29. PubMed ID: 11116861
    [No Abstract]   [Full Text] [Related]  

  • 19. Difficult wart cases -- use of imiquimod cream 5%.
    O'Mahony C
    Int J STD AIDS; 2001 Jun; 12(6):400-3. PubMed ID: 11368824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream.
    Moresi JM; Herbert CR; Cohen BA
    Pediatr Dermatol; 2001; 18(5):448-50; discussion 452. PubMed ID: 11737696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.